Safety, tolerance, and efficacy of atevirdine in asymptomatic human immunodeficiency virus-infected individuals.

Been-Tiktak, A M; Williams, I; Vrehen, H M; Richens, J; Aldam, D; van Loon, A M; Loveday, C; Boucher, C A; Ward, P; Weller, I V; Borleffs, J C

Been-Tiktak, A M; Williams, I; Vrehen, H M; Richens, J; Aldam, D; van Loon, A M; Loveday, C; Boucher, C A; Ward, P; Weller, I V; Borleffs, J C.

Affiliation

Been-Tiktak AM; Department of Internal Medicine, University Hospital Utrecht, The Netherlands.

Antimicrob Agents Chemother ; 40(11): 2664-8, 1996 Nov.

Article in En | MEDLINE | ID: mdl-8913487

Subject(s)

Anti-HIV Agents/therapeutic use; HIV Infections/drug therapy; Piperazines/therapeutic use; Adult; Anti-HIV Agents/adverse effects; CD4 Lymphocyte Count; Double-Blind Method; HIV Infections/immunology; HIV Infections/virology; Humans; Male; Piperazines/adverse effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / HIV Infections / Anti-HIV Agents Type of study: Clinical_trials Limits: Adult / Humans / Male Language: En Journal: Antimicrob Agents Chemother Year: 1996 Document type: Article Affiliation country: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google